Clinical Program Lead — RNA Therapeutics

Haya Therapeutics SA; Schweiz; Remote; CHF 140.000 - 200.000; Vollzeit

Zusammenfassung

The Clinical Program Manager at HAYA Therapeutics acts as the central contact for a program, enabling seamless transition from nomination through clinical phases to ensure timely, budget-conscious, high-quality delivery of assets.

It coordinates cross-functional activities across clinical, nonclinical, biomarkers, CMC, regulatory, and quality to align milestones, plans, and risk mitigation for on-target execution.

Qualifikationen

• Proven clinical program management experience across early development to clinical phases.
• Demonstrated capability in global drug development planning and timeline remediation.
• Financial forecasting, budget tracking, and management of CRO milestones.
• Analytical problem solving with robust ADR (Actions, Decisions, Risks) logs.
• Proficiency in MS Project, Excel, PowerPoint, and Outlook for cross-functional coordination.

Aufgaben

• Lead cross-functional program activities across clinical, nonclinical, biomarkers, CMC, regulatory and quality to ensure synchronized progression.
• Consolidate integrated program timelines and operational plans to proactively resolve bottlenecks and maintain on-target execution of milestones.
• Coordinate supply schedules and data deliverables to ensure timely availability of trial materials and safety profiles.
• Incorporate regulatory and quality assurance guidance to maintain compliance throughout the development lifecycle.
• Manage program scope, monthly forecasts, and budget changes with variance tracking.
• Maintain ADR logs to enable proactive issue mitigation and leadership visibility.

Kenntnisse

Cross-functional collaboration

Risk management

Data reporting

Financial analysis

Vendor management

Regulatory knowledge

Tools

MS Project

Excel

PowerPoint

Outlook

Jobbeschreibung

The Clinical Program Manager at HAYA Therapeutics acts as the central contact for a program, enabling seamless transition from nomination through clinical phases to ensure timely, budget-conscious, high-quality delivery of assets.

It coordinates cross-functional activities across clinical, nonclinical, biomarkers, CMC, regulatory, and quality to align milestones, plans, and risk mitigation for on-target execution.